Connect with us

National

Convalescent plasma coronavirus treatment granted emergency use authorisation in US by FDA – ABC News

The US Food and Drug Administration says there’s still more research to be done on convalescent plasma treatments for coronavirus, but the President suggests it was held up for “political” reasons.

Published

on

post featured image

US President Donald Trump has claimed credit for the US Food and Drug Administration’s (FDA) approval of the use of convalescent plasma from recovered COVID-19 patients in treating the disease.
It’s based on a well-known treatment and is being researched around the world, but it has become a political issue in the US.
Here’s why.
Approval reportedly delayed by Fauci
Researchers have been trialling blood plasma treatments for COVID-19 in the US, with similar research being carried out in A…

Click here to view the original article.